Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
joint venture
Biotech
BioLineRx forges joint cancer venture with Norwegian biotech
The Israeli drug developer will manage, fund and perform all development activities for GLIX1, a small-molecule glioblastoma candidate.
Darren Incorvaia
Sep 29, 2025 11:22am
Olympus forms GI robotics startup with Revival Healthcare
Jul 25, 2025 11:50am
OS Therapies sets up subsidiary to seek ADC joint ventures
Feb 24, 2025 9:30am
Fosun, Treehill join forces to invest in drugs angling for US
Nov 20, 2023 6:30am
GE HealthCare, Sinopharm plan imaging-focused joint venture
Feb 27, 2023 11:11am
Kinnate buys OrbiMed's stake in cancer JV to go solo in China
Feb 22, 2023 9:30am
